Patience is a virtue: An argument for delayed surgical intervention in fulminant clostridium difficile colitis

American Surgeon

Volumn 80, Issue 6, 2014, Pages 614-619

  Clanton, Jesse ^a   Fawley, Ryan ^b   Haller, Nairmeen ^c   Daley, Timothy ^d   Porter, Joel ^a   Paranjape, Charudutt ^c   Bonilla, Hector ^e  

^a AKRON CITY HOSPITAL   (United States)

^b NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^c AKRON GENERAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; HYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL PAIN; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COLITIS; COLON RESECTION; CRITICALLY ILL PATIENT; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE SEVERITY; DRUG USE; FEVER; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; INCIDENCE; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MORTALITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; THERAPY DELAY; TREATMENT INDICATION; UNITED STATES; CONFIDENCE INTERVAL; DELAYED DIAGNOSIS; METHODOLOGY; MULTICENTER STUDY; PREOPERATIVE CARE; PSEUDOMEMBRANOUS COLITIS; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME;

ANTI-BACTERIAL AGENTS; COLECTOMY; CONFIDENCE INTERVALS; DELAYED DIAGNOSIS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; ODDS RATIO; OHIO; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 84904858653     PISSN: 00031348     EISSN: 15559823     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Barbut F, Jones G, Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis 2011;24:370-6.
2. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189:1585-9.
3. Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012;61:157-62.
4. Wenisch JM, Schmid D, Tucek G, et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection 2012;40:479-84.
5. Jarvis WR, Schlosser J, Jarvis AA, et al. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009;37:263-70.
6. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012;143:1179.
7. Gonenne J, Pardi DS. Clostridium difficile: an update. Compr Ther 2004;30:134-40.
8. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995;38:350-4.
9. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-72.
10. Ngo JT, Parkins MD, Gregson DB, et al. Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections. Infection 2013;41:41-8.
11. Hemminger J, Balada-Llasat JM, Raczkowski M, et al. Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain. Infection 2011;39:371-3.
12. Crook DW, Walker AS, Kean Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clin Infect Dis 2012;55(suppl 2):S93-103.
13. Joseph J, Singhal S, Patel GM, et al. Clostridium difficile colitis: review of the therapeutic approach. Am J Ther 2012 Sept 17 [Epub ahead of print].
14. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-90.
15. Fernandez A, Anand G, Friedenberg F. Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004;38:414-8.
16. Bossé D, Lemire C, Ruel J, et al. Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection. Infection 2013;41:579-82.
17. Al-Nassir WN, Sethi AK, Nerandzic MM, et al. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis 2008;47:56-62.
18. Bhangu A, Nepogodiev D, Gupta A, et al.; on behalf of the West Midlands Research Collaborative. Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis. Br J Surg 2012;99:1501-13.
19. Miller M, Gravel D, Mulvey M, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010;50:194-201.
20. Hell M, Permoser M, Chmelizek G, et al. Clostridium difficile infection: monoclonal or polyclonal genesis? Infection 2011;39:461-5.
21. Butala P, Divino CM. Surgical aspects of fulminant Clostridium difficile colitis. Am J Surg 2010;200:131-5.
22. Bradbury AW, Barrett S. Surgical aspects of Clostridium difficile colitis. Br J Surg 1997;84:150-9.
23. Synnott K, Mealy K, Merry C, et al. Timing of surgery for fulminating pseudomembranous colitis. Br J Surg 1998;85:229-31.
24. Miller MA, Louie T, Mullane K, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis 2013;13:148.
25. Markelov A, Livert D, Kohli H. Predictors of fatal outcome after colectomy for fulminant Clostridium difficile colitis: a 10-year experience. Am Surg 2011;77:977-80.
26. Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg 2008;196:384-8.
27. Byrn JC, Maun DC, Gingold DS, et al. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg 2008;143:150-4.
28. Lipsett PA, Samantaray DK, Tam ML, et al. Pseudomembranous colitis: a surgical disease? Surgery 1994;116:491-6.
29. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-41.
30. Grundfest-Broniatowski S, Quader M, Alexander F, et al. Clostridium difficile colitis in the critically ill. Dis Colon Rectum 1996;39:619-23.
31. Neal MD, Alverdy JC, Hall DE, et al. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg 2011;254:423-9.
32. Postigo R, Kim JH. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis. Infection 2012;40:643-8.
33. Duplessis CA, You D, Johnson M, et al. Efficacious outcome employing fecal bacteriotherapy in severe Crohn's colitis complicated by refractory Clostridium difficile infection. Infection 2012;40:469-72.
34. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-15.